SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-004680
Filing Date
2019-02-27
Accepted
2019-02-27 08:23:27
Documents
78
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ntla-10k_20181231.htm 10-K 3020594
2 EX-10.19 ntla-ex1019_488.htm EX-10.19 37587
3 EX-21.1 ntla-ex211_9.htm EX-21.1 3521
4 EX-23.1 ntla-ex231_7.htm EX-23.1 4122
5 EX-31.1 ntla-ex311_8.htm EX-31.1 8838
6 EX-31.2 ntla-ex312_10.htm EX-31.2 8732
7 EX-32.1 ntla-ex321_6.htm EX-32.1 7370
8 GRAPHIC gbi3k54lvgon000002.jpg GRAPHIC 31562
9 GRAPHIC gbi3k54lvgon000003.jpg GRAPHIC 76324
10 GRAPHIC gbi3k54lvgon000001.jpg GRAPHIC 76324
  Complete submission text file 0001564590-19-004680.txt   10130096

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT ntla-20181231.xml EX-101.INS 2244059
12 XBRL TAXONOMY EXTENSION SCHEMA ntla-20181231.xsd EX-101.SCH 58179
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ntla-20181231_cal.xml EX-101.CAL 46990
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ntla-20181231_def.xml EX-101.DEF 177587
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntla-20181231_lab.xml EX-101.LAB 452982
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntla-20181231_pre.xml EX-101.PRE 343549
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37766 | Film No.: 19635884
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences